Rejoyn represents a novel and exciting adjunctive treatment option to address major depressive disorder symptoms that complements the current standard of care.
Depression is one of the most common mental health disorders in the US, with up to 30% of people on antidepressants being partial responders.
#rejoyn #major-depressive-disorder #fda-clearance #antidepressant-medications #mental-health-disorders
[
add
]
[
|
|
...
]